Progressive HIV-1 disease is accompanied by high viral loads and depletion of circulating CD4+ T cells, leading to a state of profound immunodeficiency. Such cell loss may be caused by accelerated destruction of mature T cells; it may also be due to the fact that HIV-1 interferes with the ability of the body to make new T cells from the bone marrow and/or thymus. Consistent with the latter hypothesis (of """"""""regenerative failure"""""""") is the fact that many HIV-1-infected patients have deficits not only of CD4+ T cells but of other blood lineages as well. It is the central hypothesis of this proposal that HIV-1 infection leads to destruction and/or dysfunc:ion of the bone marrow and thymic microenvironments which enable multilineage and lineage-committed hematopoiesis. We will take advantage of a novel system for the analysis of human hematopoiesis in vitro, the human bone marrow microaggregate (or """"""""MAG"""""""") culture, which has been developed during the previous funding period of this grant. In preliminary experiments, MAG cultures have been found to support multilineage and lineage-committed human hematopoiesis for periods of time as long as 8 days and to be permissive for HIV-1 infection. Results from these experiments will be correlated with those obtained from studies of bone marrow cell turnover in HIV-1-infected subjects, using a novel technique for the quantitation of cell production in vivo, the deuterated glucose technique. We will specifically address the hypothesis that HIV-1 suppresses multilineage hematopoiesis in the bone marrow microenvironment by inhibiting proliferation, differentiation, or survival of hematopoietic progenitor cells. Using this two-pronged approach, the following specific aims will be addressed:
Specific Aim 1. To optimize HIV-1 infection of human bone marrow microaggregate cultures and to characterize HIV-1-induced effects on cell proliferation, differentiation, and survival.
Specific Aim 2. To determine whether hematopoietic cell turnover in the bone marrow is altered by HIV-1 infection.
Specific Aim 3. To investigate potential mechanisms of HIV-1-inducedhematosuppression in the bone marrow microaggregate cultures, including (a) modulation of hematopoietic cytokines and (b) interruption of cell-cell contacts via adhesion molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI040312-13
Application #
7189022
Study Section
Special Emphasis Panel (NSS)
Program Officer
Bridges, Sandra H
Project Start
1996-04-01
Project End
2010-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
13
Fiscal Year
2007
Total Cost
$524,704
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ladell, Kristin; Hazenberg, Mette D; Fitch, Mark et al. (2015) Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol 195:4096-105
Seu, Lillian; Ortiz, Gabriel M; Burt, Trevor D et al. (2014) Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV disease. AIDS Res Ther 11:27
Dunham, Richard M; Vujkovic-Cvijin, Ivan; Yukl, Steven A et al. (2014) Discordance between peripheral and colonic markers of inflammation during suppressive ART. J Acquir Immune Defic Syndr 65:133-41
Vujkovic-Cvijin, Ivan; Dunham, Richard M; Iwai, Shoko et al. (2013) Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 5:193ra91
Miller, Corey N; Hartigan-O'Connor, Dennis J; Lee, Myeong Sup et al. (2013) IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia. Int Immunol 25:471-83
Seu, Lillian; Ortiz, Gabriel M; Epling, Lorrie et al. (2013) Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection. PLoS One 8:e84091
Baum, Paul D; Young, Jennifer J; Schmidt, Diane et al. (2012) Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists. Blood 119:3469-77
Sacre, Karim; Hunt, Peter W; Hsue, Priscilla Y et al. (2012) A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS 26:805-14
Seu, L; Burt, T D; Witte, J S et al. (2012) Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African-Americans. Genes Immun 13:258-67
Kiem, Hans-Peter; Jerome, Keith R; Deeks, Steven G et al. (2012) Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell 10:137-47

Showing the most recent 10 out of 49 publications